Overview

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: EMD 121974 may stop the growth of cancer by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of EMD 121974 in treating patients who have locally advanced or metastatic cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Indiana University School of Medicine
Collaborator:
National Cancer Institute (NCI)